Discovering LINC00654: A Potential Drug Target Or Biomarker (G149837)

Target Name: LINC00654

NCBI ID: G149837

LINC00654

Other Name(s): Long intergenic non-protein coding RNA 654 | long intergenic non-protein coding RNA 654

Discovering LINC00654: A Potential Drug Target Or Biomarker

LINC00654 is a non-protein coding RNA (ncRNA) molecule that has been identified in various studies as having the potential to be a drug target or biomarker. LINC00654 is a long non-coding RNA molecule that is located between the intron and the 5' end of gene LINC00653, which is located on chromosome 16.1.

The discovery of LINC00654 comes from a study by a research group led by Dr. Yueh-Fen Tsai at the University of California, San Diego. The researchers used RNA sequencing technology to identify LINC00654 as a novel RNA molecule in the LINC00653 gene.

LINC00654 is characterized by its long length, which is over 2000 nucleotides long. It is also expressed in a variety of tissues and cells, including the brain, heart, and liver. Additionally, LINC00654 has been shown to be involved in various cellular processes, including cell signaling, cell division, and gene regulation.

One of the key features of LINC00654 is its ability to interact with other molecules. Studies have shown that LINC00654 can form a complex with the protein PSBP, which is a known regulator of gene expression. Additionally, LINC00654 has been shown to interact with the RNA Binding protein RNA-Binding Protein (RBP), which is involved in the regulation of gene expression.

Another potential mechanism by which LINC00654 may be involved in drug development is its role as a biomarker. Studies have shown that LINC00654 has been expressed in various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Additionally, LINC00654 has been shown to be involved in the regulation of cellular processes that are implicated in disease development.

In addition to its potential as a drug target or biomarker, LINC00654 also has potential as a research tool. The long non-coding RNA molecule is relatively stable and can be easily amplified using RNA amplification techniques. Additionally, the structure of LINC00654 can be determined using bioinformatics tools, which can provide insights into the three-dimensional structure of the molecule.

In conclusion, LINC00654 is a novel non-protein coding RNA molecule that has the potential to be a drug target or biomarker. Its long non-coding nature and various cellular processes involved in its regulation make it an interesting molecule for further study. Further research is needed to determine the full role of LINC00654 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 654

The "LINC00654 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00654 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets